Preoperative HBA1c and risk of postoperative complications in patients with gynaecological cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-07

AUTHORS

C. Iavazzo, M. McComiskey, M. Datta, M. Ryan, J. Kiernan, B. Winter-Roach, R. Slade, M. Smith

ABSTRACT

BACKGROUND: HBA1c is used as an indicator for the long-term control of the glycaemic state and outcome predictors in diabetic patients. Diabetic patients have an increased risk of post-operative complications especially those related to infection. The aim of our study is to ascertain the relationship between HBA1c levels and post-operative recovery within the subspecialty of gynaecological oncology. METHOD: Prospective cohort study during the period 1 August 2012 through 31 August 2014. Preoperative measurement of HBA1c on all gynaecological oncology patients that underwent major surgery. Patient variables collected and analysed were BMI (kg/m(2)), length of stay (LOS in days), cancer stage (stage 1 through stage 4), infective complications, non-infective complications and readmission to hospital. RESULTS: A total of 300 patients were included in our study, 34 of them were known to be diabetic while 266 were presumed to be non-diabetic. Of the presumed non-diabetic cohort, 17.3 % (46/266) had impaired glucose tolerance or diabetes. Mean BMI was significantly increased in the pre-existing diabetic group (32.8 vs. 29.3 kg/m(2), p = 0.016). Infective complications were almost double the rate amongst the known diabetic women than those presumed to be non-diabetic (32.4 vs. 18.0 %, p = 0.048). Rate of re-admission to hospital due to complications was 20.6 % in the diabetic group and 4.1 % within the presumed non-diabetic group (p < 0.001). Infective complications occurred in 16.9 % of women with HBA1c <42 mmol/mol, 22.7 % of those with HBA1c of 42-47 mmol/mol, 43.5 % of patients with HBA1c 48-64 mmol/mol and 37.5 % of patients with HBA1c >64 mmol/mol. Non-infective complications were also more frequent in women with elevated HBA1c (11.1, 22.7, 26.1 and 12.5 % in those women with HBA1c <42, 42-47, 48-64 and >64 mmol/mol, respectively). Re-admission to hospital within 30 days for a complication of surgery occurred in 4.4 % of women with HBA1c <42 mmol/mol, 4.5 % of women with HBA1c measured at 42-47 mmol/mol, 30.8 % of those with HBA1c 48-64 mmol/mol and 25 % of women with HBA1c >64 mmol/mol. CONCLUSION: Preoperative measurement of HBA1c may identify patients (both diabetic and non-diabetic women) at higher risk of postoperative complications and could be used as a trigger for modification of the perioperative management of such patients. More... »

PAGES

161-164

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00404-015-3983-8

DOI

http://dx.doi.org/10.1007/s00404-015-3983-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021763133

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26676831


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genital Neoplasms, Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucose Intolerance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gynecologic Surgical Procedures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Length of Stay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Outcome Assessment (Health Care)", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Complications", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Preoperative Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Preoperative Period", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "Gynaecological Oncology Department, Christie Hospital, 550 Wilmslow Rd, M20 4BX, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iavazzo", 
        "givenName": "C.", 
        "id": "sg:person.01001644037.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001644037.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "Gynaecological Oncology Department, Christie Hospital, 550 Wilmslow Rd, M20 4BX, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McComiskey", 
        "givenName": "M.", 
        "id": "sg:person.0611775047.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611775047.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "Gynaecological Oncology Department, Christie Hospital, 550 Wilmslow Rd, M20 4BX, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Datta", 
        "givenName": "M.", 
        "id": "sg:person.0726223447.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726223447.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "Gynaecological Oncology Department, Christie Hospital, 550 Wilmslow Rd, M20 4BX, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ryan", 
        "givenName": "M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "Gynaecological Oncology Department, Christie Hospital, 550 Wilmslow Rd, M20 4BX, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kiernan", 
        "givenName": "J.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "Gynaecological Oncology Department, Christie Hospital, 550 Wilmslow Rd, M20 4BX, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Winter-Roach", 
        "givenName": "B.", 
        "id": "sg:person.0740560665.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740560665.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "Gynaecological Oncology Department, Christie Hospital, 550 Wilmslow Rd, M20 4BX, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Slade", 
        "givenName": "R.", 
        "id": "sg:person.0626371405.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626371405.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "Gynaecological Oncology Department, Christie Hospital, 550 Wilmslow Rd, M20 4BX, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "M.", 
        "id": "sg:person.01225013647.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225013647.73"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6604313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004248817", 
          "https://doi.org/10.1038/sj.bjc.6604313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bjs.6724", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007338152"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bjs.6724", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007338152"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejvs.2006.01.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009175459"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/cclm.2002.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010006537"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijsu.2015.02.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015928028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1055-9965.epi-07-2567", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017313015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2014.630", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019176091", 
          "https://doi.org/10.1038/bjc.2014.630"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc10-0304", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025940958"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2012.03582.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030987886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12630-010-9294-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032474084", 
          "https://doi.org/10.1007/s12630-010-9294-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12630-010-9294-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032474084", 
          "https://doi.org/10.1007/s12630-010-9294-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.39367.495995.ae", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042706326"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-07", 
    "datePublishedReg": "2016-07-01", 
    "description": "BACKGROUND: HBA1c is used as an indicator for the long-term control of the glycaemic state and outcome predictors in diabetic patients. Diabetic patients have an increased risk of post-operative complications especially those related to infection. The aim of our study is to ascertain the relationship between HBA1c levels and post-operative recovery within the subspecialty of gynaecological oncology.\nMETHOD: Prospective cohort study during the period 1 August 2012 through 31 August 2014. Preoperative measurement of HBA1c on all gynaecological oncology patients that underwent major surgery. Patient variables collected and analysed were BMI (kg/m(2)), length of stay (LOS in days), cancer stage (stage 1 through stage 4), infective complications, non-infective complications and readmission to hospital.\nRESULTS: A total of 300 patients were included in our study, 34 of them were known to be diabetic while 266 were presumed to be non-diabetic. Of the presumed non-diabetic cohort, 17.3\u00a0% (46/266) had impaired glucose tolerance or diabetes. Mean BMI was significantly increased in the pre-existing diabetic group (32.8 vs. 29.3\u00a0kg/m(2), p\u00a0=\u00a00.016). Infective complications were almost double the rate amongst the known diabetic women than those presumed to be non-diabetic (32.4 vs. 18.0\u00a0%, p\u00a0=\u00a00.048). Rate of re-admission to hospital due to complications was 20.6\u00a0% in the diabetic group and 4.1\u00a0% within the presumed non-diabetic group (p\u00a0<\u00a00.001). Infective complications occurred in 16.9\u00a0% of women with HBA1c <42\u00a0mmol/mol, 22.7\u00a0% of those with HBA1c of 42-47\u00a0mmol/mol, 43.5\u00a0% of patients with HBA1c 48-64\u00a0mmol/mol and 37.5\u00a0% of patients with HBA1c >64\u00a0mmol/mol. Non-infective complications were also more frequent in women with elevated HBA1c (11.1, 22.7, 26.1 and 12.5\u00a0% in those women with HBA1c <42, 42-47, 48-64 and >64\u00a0mmol/mol, respectively). Re-admission to hospital within 30\u00a0days for a complication of surgery occurred in 4.4\u00a0% of women with HBA1c <42\u00a0mmol/mol, 4.5\u00a0% of women with HBA1c measured at 42-47\u00a0mmol/mol, 30.8\u00a0% of those with HBA1c 48-64\u00a0mmol/mol and 25\u00a0% of women with HBA1c >64\u00a0mmol/mol.\nCONCLUSION: Preoperative measurement of HBA1c may identify patients (both diabetic and non-diabetic women) at higher risk of postoperative complications and could be used as a trigger for modification of the perioperative management of such patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00404-015-3983-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017365", 
        "issn": [
          "0932-0067", 
          "1432-0711"
        ], 
        "name": "Archives of Gynecology and Obstetrics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "294"
      }
    ], 
    "name": "Preoperative HBA1c and risk of postoperative complications in patients with gynaecological cancer", 
    "pagination": "161-164", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "67b034b629598de30992470d4fee6e839aa0df6b868ffa5770d91ebeeaee6c07"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26676831"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8710213"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00404-015-3983-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021763133"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00404-015-3983-8", 
      "https://app.dimensions.ai/details/publication/pub.1021763133"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000512.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00404-015-3983-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00404-015-3983-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00404-015-3983-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00404-015-3983-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00404-015-3983-8'


 

This table displays all metadata directly associated to this object as RDF triples.

224 TRIPLES      21 PREDICATES      58 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00404-015-3983-8 schema:about N02e15e689e0f4e569d62c70622550e2e
2 N1650315f3e8543499c06520ea4b3e24d
3 N167e1e1aed1147efb60e57aeb62c1bee
4 N26c8940bd21448f580173e31d2e782ee
5 N2c1411c9c92149018c84d580bfb97b66
6 N3e0d0a013dbe42afb667de00011e3878
7 N5ac4123707a34f769a5b2fc36e76927b
8 N645223470d7b4966a18d08655a94b2a3
9 N6617653c08d946fd92a277c15d61d985
10 N87f1dbdb519342b888826449f3d69a23
11 N9e20cff2e07a431383899c5dd2668a8e
12 Na25d9a7bd89c4f4fa53c3f67a00775fc
13 Naceca9864c724911a623327f3b5e3240
14 Ncc103a04e4814e98973b80cae062ff02
15 Ne43caabfee9643febf8649552364c4e8
16 Ne606a121f0874c38b3e9ca6512f2325c
17 Nf094fb0c2b2b4881b39b31529134681b
18 Nf4bf1619bb174f77897214923998786f
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author N9a1c3b9ced074a7ba6ced60c9427bfd2
22 schema:citation sg:pub.10.1007/s12630-010-9294-4
23 sg:pub.10.1038/bjc.2014.630
24 sg:pub.10.1038/sj.bjc.6604313
25 https://doi.org/10.1002/bjs.6724
26 https://doi.org/10.1016/j.ejvs.2006.01.011
27 https://doi.org/10.1016/j.ijsu.2015.02.008
28 https://doi.org/10.1111/j.1464-5491.2012.03582.x
29 https://doi.org/10.1136/bmj.39367.495995.ae
30 https://doi.org/10.1158/1055-9965.epi-07-2567
31 https://doi.org/10.1515/cclm.2002.016
32 https://doi.org/10.2337/dc10-0304
33 schema:datePublished 2016-07
34 schema:datePublishedReg 2016-07-01
35 schema:description BACKGROUND: HBA1c is used as an indicator for the long-term control of the glycaemic state and outcome predictors in diabetic patients. Diabetic patients have an increased risk of post-operative complications especially those related to infection. The aim of our study is to ascertain the relationship between HBA1c levels and post-operative recovery within the subspecialty of gynaecological oncology. METHOD: Prospective cohort study during the period 1 August 2012 through 31 August 2014. Preoperative measurement of HBA1c on all gynaecological oncology patients that underwent major surgery. Patient variables collected and analysed were BMI (kg/m(2)), length of stay (LOS in days), cancer stage (stage 1 through stage 4), infective complications, non-infective complications and readmission to hospital. RESULTS: A total of 300 patients were included in our study, 34 of them were known to be diabetic while 266 were presumed to be non-diabetic. Of the presumed non-diabetic cohort, 17.3 % (46/266) had impaired glucose tolerance or diabetes. Mean BMI was significantly increased in the pre-existing diabetic group (32.8 vs. 29.3 kg/m(2), p = 0.016). Infective complications were almost double the rate amongst the known diabetic women than those presumed to be non-diabetic (32.4 vs. 18.0 %, p = 0.048). Rate of re-admission to hospital due to complications was 20.6 % in the diabetic group and 4.1 % within the presumed non-diabetic group (p < 0.001). Infective complications occurred in 16.9 % of women with HBA1c <42 mmol/mol, 22.7 % of those with HBA1c of 42-47 mmol/mol, 43.5 % of patients with HBA1c 48-64 mmol/mol and 37.5 % of patients with HBA1c >64 mmol/mol. Non-infective complications were also more frequent in women with elevated HBA1c (11.1, 22.7, 26.1 and 12.5 % in those women with HBA1c <42, 42-47, 48-64 and >64 mmol/mol, respectively). Re-admission to hospital within 30 days for a complication of surgery occurred in 4.4 % of women with HBA1c <42 mmol/mol, 4.5 % of women with HBA1c measured at 42-47 mmol/mol, 30.8 % of those with HBA1c 48-64 mmol/mol and 25 % of women with HBA1c >64 mmol/mol. CONCLUSION: Preoperative measurement of HBA1c may identify patients (both diabetic and non-diabetic women) at higher risk of postoperative complications and could be used as a trigger for modification of the perioperative management of such patients.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree false
39 schema:isPartOf N69888b3d6adf4a77a2b6969ddbb364ae
40 Naed76769906c4afc840db1c960ecccb1
41 sg:journal.1017365
42 schema:name Preoperative HBA1c and risk of postoperative complications in patients with gynaecological cancer
43 schema:pagination 161-164
44 schema:productId N38733fc11ec84aef976ff9b55e8a6540
45 N77ac3877a9aa4479a78231756518e0fc
46 N88fcad46c82c42f69e971eac2bb8a954
47 N994690f2517e4685a37c784425533968
48 N9e7980bb5b9d4a5e85d2fe67dfa91dbb
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021763133
50 https://doi.org/10.1007/s00404-015-3983-8
51 schema:sdDatePublished 2019-04-10T19:57
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher N795b3335bc7f45319ad6dd7c3cef528d
54 schema:url http://link.springer.com/10.1007%2Fs00404-015-3983-8
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N02e15e689e0f4e569d62c70622550e2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Preoperative Period
60 rdf:type schema:DefinedTerm
61 N1650315f3e8543499c06520ea4b3e24d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Glucose Intolerance
63 rdf:type schema:DefinedTerm
64 N167e1e1aed1147efb60e57aeb62c1bee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Prognosis
66 rdf:type schema:DefinedTerm
67 N17239be276114246863d5eae01260e8c rdf:first sg:person.0726223447.17
68 rdf:rest N738dfc568a4c4a51afbd6cd5b4505b38
69 N26c8940bd21448f580173e31d2e782ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Diabetes Mellitus
71 rdf:type schema:DefinedTerm
72 N2c1411c9c92149018c84d580bfb97b66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Infection
74 rdf:type schema:DefinedTerm
75 N38733fc11ec84aef976ff9b55e8a6540 schema:name pubmed_id
76 schema:value 26676831
77 rdf:type schema:PropertyValue
78 N3e0d0a013dbe42afb667de00011e3878 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Risk
80 rdf:type schema:DefinedTerm
81 N4b3bfa9f14e14c4e9ad569d2a087361c rdf:first Na6506b5d11144b7397ba75c638dc713d
82 rdf:rest N8a714f78098847d1852b851464feeb98
83 N5ac4123707a34f769a5b2fc36e76927b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Length of Stay
85 rdf:type schema:DefinedTerm
86 N603ddb5377374fa19f1eb24a82ba02be rdf:first sg:person.0611775047.07
87 rdf:rest N17239be276114246863d5eae01260e8c
88 N645223470d7b4966a18d08655a94b2a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Blood Glucose
90 rdf:type schema:DefinedTerm
91 N6617653c08d946fd92a277c15d61d985 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Humans
93 rdf:type schema:DefinedTerm
94 N69888b3d6adf4a77a2b6969ddbb364ae schema:volumeNumber 294
95 rdf:type schema:PublicationVolume
96 N738dfc568a4c4a51afbd6cd5b4505b38 rdf:first Nd36aa4d3491945a3803b86417721323e
97 rdf:rest N4b3bfa9f14e14c4e9ad569d2a087361c
98 N77ac3877a9aa4479a78231756518e0fc schema:name dimensions_id
99 schema:value pub.1021763133
100 rdf:type schema:PropertyValue
101 N795b3335bc7f45319ad6dd7c3cef528d schema:name Springer Nature - SN SciGraph project
102 rdf:type schema:Organization
103 N87f1dbdb519342b888826449f3d69a23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Middle Aged
105 rdf:type schema:DefinedTerm
106 N88fcad46c82c42f69e971eac2bb8a954 schema:name nlm_unique_id
107 schema:value 8710213
108 rdf:type schema:PropertyValue
109 N8a714f78098847d1852b851464feeb98 rdf:first sg:person.0740560665.15
110 rdf:rest Na7b12636b1b44276b55d8298e1cfa3e7
111 N994690f2517e4685a37c784425533968 schema:name readcube_id
112 schema:value 67b034b629598de30992470d4fee6e839aa0df6b868ffa5770d91ebeeaee6c07
113 rdf:type schema:PropertyValue
114 N9a1c3b9ced074a7ba6ced60c9427bfd2 rdf:first sg:person.01001644037.74
115 rdf:rest N603ddb5377374fa19f1eb24a82ba02be
116 N9e20cff2e07a431383899c5dd2668a8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Preoperative Care
118 rdf:type schema:DefinedTerm
119 N9e7980bb5b9d4a5e85d2fe67dfa91dbb schema:name doi
120 schema:value 10.1007/s00404-015-3983-8
121 rdf:type schema:PropertyValue
122 Na25d9a7bd89c4f4fa53c3f67a00775fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Prospective Studies
124 rdf:type schema:DefinedTerm
125 Na6506b5d11144b7397ba75c638dc713d schema:affiliation https://www.grid.ac/institutes/grid.415720.5
126 schema:familyName Kiernan
127 schema:givenName J.
128 rdf:type schema:Person
129 Na7b12636b1b44276b55d8298e1cfa3e7 rdf:first sg:person.0626371405.86
130 rdf:rest Nffb2cd8aba8f4f84a36023cad9305b59
131 Naceca9864c724911a623327f3b5e3240 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Postoperative Complications
133 rdf:type schema:DefinedTerm
134 Naed76769906c4afc840db1c960ecccb1 schema:issueNumber 1
135 rdf:type schema:PublicationIssue
136 Ncc103a04e4814e98973b80cae062ff02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Female
138 rdf:type schema:DefinedTerm
139 Nd36aa4d3491945a3803b86417721323e schema:affiliation https://www.grid.ac/institutes/grid.415720.5
140 schema:familyName Ryan
141 schema:givenName M.
142 rdf:type schema:Person
143 Ne43caabfee9643febf8649552364c4e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Outcome Assessment (Health Care)
145 rdf:type schema:DefinedTerm
146 Ne606a121f0874c38b3e9ca6512f2325c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Genital Neoplasms, Female
148 rdf:type schema:DefinedTerm
149 Nf094fb0c2b2b4881b39b31529134681b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Glycated Hemoglobin A
151 rdf:type schema:DefinedTerm
152 Nf4bf1619bb174f77897214923998786f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Gynecologic Surgical Procedures
154 rdf:type schema:DefinedTerm
155 Nffb2cd8aba8f4f84a36023cad9305b59 rdf:first sg:person.01225013647.73
156 rdf:rest rdf:nil
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
161 schema:name Clinical Sciences
162 rdf:type schema:DefinedTerm
163 sg:journal.1017365 schema:issn 0932-0067
164 1432-0711
165 schema:name Archives of Gynecology and Obstetrics
166 rdf:type schema:Periodical
167 sg:person.01001644037.74 schema:affiliation https://www.grid.ac/institutes/grid.415720.5
168 schema:familyName Iavazzo
169 schema:givenName C.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001644037.74
171 rdf:type schema:Person
172 sg:person.01225013647.73 schema:affiliation https://www.grid.ac/institutes/grid.415720.5
173 schema:familyName Smith
174 schema:givenName M.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225013647.73
176 rdf:type schema:Person
177 sg:person.0611775047.07 schema:affiliation https://www.grid.ac/institutes/grid.415720.5
178 schema:familyName McComiskey
179 schema:givenName M.
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611775047.07
181 rdf:type schema:Person
182 sg:person.0626371405.86 schema:affiliation https://www.grid.ac/institutes/grid.415720.5
183 schema:familyName Slade
184 schema:givenName R.
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626371405.86
186 rdf:type schema:Person
187 sg:person.0726223447.17 schema:affiliation https://www.grid.ac/institutes/grid.415720.5
188 schema:familyName Datta
189 schema:givenName M.
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726223447.17
191 rdf:type schema:Person
192 sg:person.0740560665.15 schema:affiliation https://www.grid.ac/institutes/grid.415720.5
193 schema:familyName Winter-Roach
194 schema:givenName B.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740560665.15
196 rdf:type schema:Person
197 sg:pub.10.1007/s12630-010-9294-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032474084
198 https://doi.org/10.1007/s12630-010-9294-4
199 rdf:type schema:CreativeWork
200 sg:pub.10.1038/bjc.2014.630 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019176091
201 https://doi.org/10.1038/bjc.2014.630
202 rdf:type schema:CreativeWork
203 sg:pub.10.1038/sj.bjc.6604313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004248817
204 https://doi.org/10.1038/sj.bjc.6604313
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1002/bjs.6724 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007338152
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/j.ejvs.2006.01.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009175459
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/j.ijsu.2015.02.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015928028
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1111/j.1464-5491.2012.03582.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1030987886
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1136/bmj.39367.495995.ae schema:sameAs https://app.dimensions.ai/details/publication/pub.1042706326
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1158/1055-9965.epi-07-2567 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017313015
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1515/cclm.2002.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010006537
219 rdf:type schema:CreativeWork
220 https://doi.org/10.2337/dc10-0304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025940958
221 rdf:type schema:CreativeWork
222 https://www.grid.ac/institutes/grid.415720.5 schema:alternateName The Christie Hospital
223 schema:name Gynaecological Oncology Department, Christie Hospital, 550 Wilmslow Rd, M20 4BX, Manchester, UK
224 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...